• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » CORRECTION: SafeStitch Medical issues shares in TransEnterix merger

CORRECTION: SafeStitch Medical issues shares in TransEnterix merger

September 17, 2013 By Brad Perriello

SafeStitch Medical raises $160M

Correction, Sept. 17, 2013: Due to a reporter’s error, this article originally stated that SafeStitch raised $160 million. The company instead issued $160 million worth of shares as part of its merger with TransEnterix.

SafeStitch Medical (OTC:SFES) issued $160.4 million worth of stock as part of its merger with TransEnterix.

SafeStitch and TransEnterix inked their merger deal last month, saying SafeStitch would move from Miami to Research Triangle, N.C., but keep its name, stock symbol and place on the OTC exchange.

TransEnterix CEO Todd Pope is at the helm of the new SafeStitch, with medtech veteran Paul LaViolette as board chairman. SafeStitch chairwoman Jane Hsiao and OPKO Health chairman Phillip Frost also have seats on the new entity’s board, the company said at the time.

The merger also included a private placement worth about $30.2 million, SafeStitch said at the time. To consummate the deal, TransEnterix shareholders received nearly 106 million shares which, at $1.52 apiece, were worth $160.3 million, a spokesman told MassDevice.com today via email.

Regulatory filings show that the company’s backers include Aisling Capital, which owns a 20.3% stake; SV Life Sciences, which has a 14.0% share; Synergy Life Science Partners, which owns a 10.1% share; and Intersouth Partners, which has a 10.0% stake. Hsiao owns a 9.4% share in SafeStitch, according to the filings, with co-founder (and ex-president & CEO) Jeffrey Spragens retaining a 2.4% stake. Frost now holds an 8.5% stake.

SafeStitch, founded in 2005 by Dr. Charles Filipi (who holds a 1.7% stake in the news SafeStitch) and Spragens, makes the Amid hernia fixation device. TransEnterix made laparoscopic devices including the Spider and Starr instruments. It was founded in 2006 and raised $21 million in "institutional financing" in 2008, according to its website. Another $55 million round followed in 2009 and TransEnterix raised a further $15 million in venture capital backing in 2011.

Filed Under: Funding Roundup, News Well, Surgical Tagged With: Aisling Capital, Intersouth Partners, SafeStitch Medical, SV Life Sciences, Synergy Life Science Partners, Venture Capital/Private Equity

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy